Entry |
|
Name |
Bupivacaine hydrochloride (USP); Bupivacaine hydrochloride hydrate (JP18); Marcaine (TN) |
Product |
|
Generic |
BUPIVACAINE (Hospira), BUPIVACAINE HCI (HF Acquisition Co LLC), BUPIVACAINE HCL (Xellia Pharmaceuticals USA LLC), BUPIVACAINE HYDROCHLORIDE (A-S Medication Solutions), BUPIVACAINE HYDROCHLORIDE (Asclemed USA), BUPIVACAINE HYDROCHLORIDE (Asclemed USA), BUPIVACAINE HYDROCHLORIDE (Asclemed USA), BUPIVACAINE HYDROCHLORIDE (Asclemed USA), BUPIVACAINE HYDROCHLORIDE (Brookfield Pharmaceuticals), BUPIVACAINE HYDROCHLORIDE (Camber Pharmaceuticals), BUPIVACAINE HYDROCHLORIDE (Cardinal Health 107), BUPIVACAINE HYDROCHLORIDE (Eugia US LLC), BUPIVACAINE HYDROCHLORIDE (HF Acquisition Co LLC), BUPIVACAINE HYDROCHLORIDE (Henry Schein), BUPIVACAINE HYDROCHLORIDE (Henry Schein), BUPIVACAINE HYDROCHLORIDE (Hikma Pharmaceuticals USA), BUPIVACAINE HYDROCHLORIDE (Hikma Pharmaceuticals USA), BUPIVACAINE HYDROCHLORIDE (Huons), BUPIVACAINE HYDROCHLORIDE (Medical Purchasing Solutions), BUPIVACAINE HYDROCHLORIDE (Medical Purchasing Solutions), BUPIVACAINE HYDROCHLORIDE (Medical Purchasing Solutions), BUPIVACAINE HYDROCHLORIDE (Meitheal Pharmaceuticals), BUPIVACAINE HYDROCHLORIDE (Meitheal Pharmaceuticals), BUPIVACAINE HYDROCHLORIDE (NorthStar RxLLC), BUPIVACAINE HYDROCHLORIDE (Northstar Rx LLC), BUPIVACAINE HYDROCHLORIDE (Somerset Therapeutics), BUPIVACAINE HYDROCHLORIDE (Steriscience Specialties Private Limited), BUPIVACAINE HYDROCHLORIDE (Steriscience Specialties Private Limited), BUPIVACAINE HYDROCHLORIDE (Xellia Pharmaceuticals USA LLC), BUPIVACAINE HYDROCHLORIDE INJECTION, SOLUTION (HF Acquisition Co LLC), BUPIVACAINE HYDROCHLORIDE WITH DEXTROSE (B. Braun Medical), BUPIVICAINE HYDROCHLORIDE (HF Acquisition Co LLC), SENSORCAINE (Fresenius Kabi USA), SENSORCAINE (Fresenius Kabi USA), SENSORCAINE MPF (Henry Schein) |
Formula |
C18H28N2O. HCl. H2O
|
Exact mass |
342.2074
|
Mol weight |
342.90
|
Structure |

|
Simcomp |
|
Class |
Neuropsychiatric agent
DG02030 Anesthetics
DG01675 Local anesthetic
DG01673 Amide type local anesthetic
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
|
Remark |
Therapeutic category: | 1214 |
Product (DG00801): | D07552<US> D01450<JP/US> |
Product (mixture): | D11569<US> |
|
Efficacy |
Anesthetic (local) |
Target |
|
Pathway |
|
Metabolism |
Enzyme: CYP3A4 [HSA: 1576]
|
Interaction |
|
Structure map |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N01 ANESTHETICS
N01B ANESTHETICS, LOCAL
N01BB Amides
N01BB01 Bupivacaine
D01450 Bupivacaine hydrochloride (USP) <JP/US>
USP drug classification [BR:br08302]
Anesthetics
Local Anesthetics
Bupivacaine
D01450 Bupivacaine hydrochloride (USP)
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
12 Agents affecting peripheral nervous system
121 Local anesthetics
1214 Xylidines
D01450 Bupivacaine hydrochloride (USP); Bupivacaine hydrochloride hydrate (JP18)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG02030 Anesthetics
DG01675 Local anesthetic
DG01673 Amide type local anesthetic
DG00801 Bupivacaine
D01450 Bupivacaine hydrochloride
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00801 Bupivacaine
D01450 Bupivacaine hydrochloride
Target-based classification of drugs [BR:br08310]
Ion channels
Voltage-gated ion channels
Sodium channels
SCN1A
D01450 Bupivacaine hydrochloride (USP) <JP/US>
SCN2A
D01450 Bupivacaine hydrochloride (USP) <JP/US>
SCN3A
D01450 Bupivacaine hydrochloride (USP) <JP/US>
SCN4A
D01450 Bupivacaine hydrochloride (USP) <JP/US>
SCN5A
D01450 Bupivacaine hydrochloride (USP) <JP/US>
SCN8A
D01450 Bupivacaine hydrochloride (USP) <JP/US>
SCN9A
D01450 Bupivacaine hydrochloride (USP) <JP/US>
SCN10A
D01450 Bupivacaine hydrochloride (USP) <JP/US>
SCN11A
D01450 Bupivacaine hydrochloride (USP) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D01450 Bupivacaine hydrochloride hydrate
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D01450
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D01450
Drug groups [BR:br08330]
Neuropsychiatric agent
DG02030 Anesthetics
DG01675 Local anesthetic
DG01673 Amide type local anesthetic
DG00801 Bupivacaine
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00801 Bupivacaine
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 23
1 C1y C 22.9876 -17.0670
2 N1y N 22.9702 -18.4666
3 C5a C 21.7746 -16.3556
4 C1b C 21.7512 -19.1547
5 N1b N 20.5615 -17.0496
6 O5a O 21.7862 -14.9501
7 C1b C 20.5498 -18.4549
8 C8y C 19.4185 -16.3382
9 C1b C 19.3369 -19.1487
10 C8y C 18.1297 -17.0320
11 C8y C 19.3602 -14.9325
12 C1a C 19.3369 -20.5427
13 C8x C 16.9225 -16.3206
14 C1a C 18.1297 -18.4257
15 C8x C 18.1471 -14.2270
16 C8x C 16.9225 -14.9208
17 C1a C 20.5679 -14.2445
18 C1x C 24.1738 -19.1815
19 C1x C 25.3947 -18.4968
20 C1x C 25.4122 -17.0972
21 C1x C 24.2086 -16.3822
22 X Cl 28.3695 -17.8451
23 O0 O 31.5703 -17.8269
BOND 22
1 1 2 1
2 1 3 1
3 2 4 1
4 3 5 1
5 3 6 2
6 4 7 1
7 5 8 1
8 7 9 1
9 8 10 1
10 8 11 2
11 9 12 1
12 10 13 2
13 10 14 1
14 11 15 1
15 13 16 1
16 15 16 2
17 11 17 1
18 2 18 1
19 18 19 1
20 19 20 1
21 20 21 1
22 1 21 1
|
|